Predicting Mouse Lifespan-Extending Chemical Compounds with Machine Learning

Pharmacological interventions targeting the biological processes of ageing hold significant potential to extend healthspan and promote longevity. This, to our knowledge, is the first study that uses Machine Learning models trained specifically on mouse lifespan data (from DrugAge) to predict lifespan-extending compounds. The use of mammalian data significantly elevates translational relevance compared to previously available models trained predominately on C. elegans data. Our most successful Random Forest classifiers were trained on direct drug-target annotations, including Gene Ontology, UniProt Keywords, pathways (KEGG, Reactome, Wiki) and protein domains (InterPro), whereas models trained on gene expression (LINCS) and chemical substructures (PubChem) underperformed. Models trained on male datasets performed better than those trained on mixed-sex and female datasets, with the latter suffering from severe class imbalance due to much fewer positive-class instances. Notably, features related to G-protein coupled receptors, especially receptors for neurotransmitters, metabolic hormones and sex hormones, were identified as strong predictors of lifespan extension. We used ensemble classifiers comprised of top models to screen compounds from DrugBank, highlighting novel candidates for longevity studies. Major clusters of compounds with the highest predicted longevity-promoting effects target IGF1 and insulin receptors, beta adrenergic receptors, carbonic anhydrases, dopamine and serotonin receptors, voltage-gated potassium and calcium channels, sodium-dependent dopamine, serotonin and noradrenalin transporters, muscarinic acetylcholine receptors and adenosine receptors. We tested 22 predicted compounds in C. elegans and found that 6 of them significantly extended median lifespan: dihydroergotamine, mianserin, bromocriptine, voxtalisib, bms-754807 and solifenacine. We have also created a public web server with our top performing classifier ensembles: https://www.cs.kent.ac.uk/projects/lodprime/ Our study not only provides an important contribution to the longevity pharmacology field but also informs research on the fundamental mechanisms of ageing.